RxDoctor Payments Data

Kelly Stephens

Psychiatric/Mental Health · Claremore, OKNPI 1588113831

Payments from drug & device makers

$677in general payments, 2019–2025

Across 38 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$121
  • AbbVie$108
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$90
  • Eisai Inc.$78
  • Takeda Pharmaceuticals U.S.A., Inc.$44
  • Boston Scientific$40
  • plus $196 from 8 others

What the payments were for

  • Food & beverage$60890%
  • Education$6910%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$677 in reported general payments places this provider in the 45th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma

Medicare billing

Part B allowed, 2024
$9,904
Medicare patients
26
Services billed
118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate43$140,284
VraylarCariprazine Hcl17$23,023
TrintellixVortioxetine Hydrobromide11$5,269
Aripiprazole58$837
Duloxetine Hcl58$633
Buspirone Hcl68$625
Trazodone Hcl83$608
Hydroxyzine Pamoate49$539
Bupropion XlBupropion Hcl51$523
Fluoxetine Hcl91$443
Lurasidone Hcl13$441
Benztropine Mesylate34$376
Mirtazapine28$340
Olanzapine28$297
Divalproex Sodium ErDivalproex Sodium19$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$40$140,28443 claims
AbbVieVraylar$108$23,02317 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$44$5,26911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 231 psychiatric/mental health providers in Oklahoma.

Other psychiatric/mental health in Claremore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →